For instance, miR-186-5p inhibits oral squamous cell carcinoma progression by targeting the integrin subunit alpha 6 (ITGA6) gene, thus affecting the phosphoinositide 3-kinase (PI3K)/AKT signaling pathway [31]. This evidence concerns the gene AKT1 and oral cavity squamous cell carcinoma.